Concepedia

Author

M R Costanzo

Loyola University Chicago

Also Known As

M R Costanzo, M R Di Costanzo, M.R. Costanzo, MR Costanzo

20

Publications

583

Citations

10

H-Index

8

Concepts

All Affiliations

Loyola University ChicagoRush University Medical CenterUniversity of British Columbia
MR

About

M R Costanzo is an author at Loyola University Chicago specializing in transplantation, medicine, and cardiovascular disease.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

2

2

31

2

Transplantation

2

2

31

3

Public Health

1

1

21

4

Emergency Medicine

1

1

10

5

Epidemiology

1

1

21

M R Costanzo

×

11

Publications

568

Citations

10

H-Index

YearCitations

Aggressive treatment for postcardiac transplant lymphoproliferation

L. J. Swinnen, GM Mullen, TJ Carr,

Blood

1995

254

Prominence of coronary arterial wall lipids in human heart allografts. Implications for pathogenesis of allograft arteriopathy.

Bruce M. McManus, K.J. Horley, Janet E. Wilson,

PubMed

1995

80

Infrequency of cytomegalovirus genome in coronary arteriopathy of human heart allografts.

James M. Gulizia, Reinhard Kandolf, Tamil Kendall,

PubMed

1995

48

Comparable proximal and distal severity of intimal thickening and size of epicardial coronary arteries in transplant arteriopathy of human cardiac allografts.

Hong Lin, Janet E. Wilson, Tamil Kendall,

PubMed

1995

47

Breath pentane is a marker of acute cardiac allograft rejection.

Paul A. Sobotka, D Gupta, David M. Lansky,

PubMed

1994

40

Intracoronary ultrasound assessment of morphological and functional abnormalities associated with cardiac allograft vasculopathy.

Alain Heroux, Paul Silverman, M R Costanzo,

Circulation

1994

26

Are there specific risk factors for fatal allograft vasculopathy? An analysis of over 7,000 cardiac transplant patients

M R Costanzo, Howard J. Eisen, Rhubell Brown,

The Journal of Heart and Lung Transplantation

2001

21

Effects of methotrexate on acute rejection and cardiac allograft vasculopathy in heart transplant recipients.

M R Costanzo, D M Koch, S G Fisher,

PubMed

1997

19

Bucindolol Decreases Atrial Fibrillation Burden in Patients With Heart Failure and the <i>ADRB1</i> Arg389Arg Genotype

Jonathan P. Piccini, Christopher Dufton, Ian A. Carroll,

Circulation Arrhythmia and Electrophysiology

2021

13

Outpatient inotropic therapy in heart transplant candidates: should its use influence waiting list priority status?

Elaine Winkel, Kao W, S G Fisher,

PubMed

1998

10

Page 1